JAN 09, 2020 11:52 AM PST

Can Cancer Drugs Treat Lung Damage?

WRITTEN BY: Nouran Amin

Can therapeutics used in the treatment of cancer be a breakthrough for pulmonary disease? Specifically, chronic obstructive pulmonary disease (COPD)? “COPD is usually treated with steroids and airway muscle relaxants which ease symptoms, but there is currently no effective treatment clinically available to counteract the damage it does to the lungs,” says Dr. Lynne Prince, Russell Fellow at the University of Sheffield.

Learn more about COPD:

Individuals with COPD experience a wide range of symptoms that affect overall quality of life such as shortness of breath and chest infections.

However, these symptoms are driven by the damage that occurs to the lungs caused by a particular cell type found in our immune system—the neutrophils.

Now, researchers at the University of Sheffield have screened a library of cancer drugs to identify particles that accelerate the death of neutrophils and encourage healing in the lungs. “Our research now shows that inhibitors of these cell signaling processes, or ErbB kinases, could have therapeutic potential in neutrophilic inflammatory disease,” says Prince. “The hope of these drugs is that they can clear the damaging cells from the lungs of people living with COPD, preventing any further damage and therefore the progression of the disease for the first time.”

The goal is these drugs are repurposed to treat COPD by clearing the damage caused by the neutrophils and therefore, delaying the progression of the disease.

“We are in desperate need of a new treatment for COPD, millions of people all over the world live with the disease and it has a massive impact on their quality of life, especially as the disease progresses,” says Professor Stephen Renshaw on the clinical benefits of drug repurposing. “What is exciting about this research is that these drug compounds are available now, which means if our continued research can effectively find a lead compound to benefit people living with COPD, they are ready to use.

Source: University of Sheffield

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 16, 2020
Drug Discovery & Development
FDA Warns Against NSAIDs After Week 20 of Pregnancy
OCT 16, 2020
FDA Warns Against NSAIDs After Week 20 of Pregnancy
The US Food and Drug Administration (FDA) has warned against using nonsteroidal anti-inflammatory drugs (NSAIDs) from 20 ...
OCT 21, 2020
Drug Discovery & Development
Experimental Vaccine Shows Promise in Halting Alzheimer's
OCT 21, 2020
Experimental Vaccine Shows Promise in Halting Alzheimer's
In a preclinical study, researchers from the Univerity of South Florida have found that a vaccine that targets neurotoxi ...
OCT 21, 2020
Microbiology
The First Treatment for Ebola is Approved by FDA
OCT 21, 2020
The First Treatment for Ebola is Approved by FDA
Ebola virus can pass from animals to humans, and between people. Rarely, it causes outbreaks but when it does, they can ...
NOV 06, 2020
Drug Discovery & Development
Anti-depressant Shows Promise in Treating Childhood Cancer
NOV 06, 2020
Anti-depressant Shows Promise in Treating Childhood Cancer
Researchers from Sweden and the US have found that a commonly prescribed antidepressant may help stop the growth of a ca ...
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 12, 2020
Immunology
The Enzyme That Keeps Viruses In Stealth Mode
NOV 12, 2020
The Enzyme That Keeps Viruses In Stealth Mode
Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic inf ...
Loading Comments...